Donald Gordon FDA
Showing 22 results for "gordon-donald-g"
DGG
$695 - Available for Instant Download The most comprehensive report on Donald Gordon's FDA inspection metrics, details, citations, trends and more.
SpecGx 483 Mar 2002
$119.00 - Available for Instant DownloadIssued: 13 Mar 2002Type: Human DrugsSpecGx - Hobart, NY, United States
Allyn M. Norman, DO 483 Aug 2001
$119.00 - Available for Instant DownloadIssued: 23 Aug 2001Type: Human DrugsAllyn M. Norman, DO - Getzville, NY, United States
Allyn M. Norman, DO EIR Aug 2001
$595.00 - Available for Instant DownloadIssued: 23 Aug 2001Type: Human DrugsAllyn M. Norman, DO - Getzville, NY, United States
Ortho Clinical Diagnostics EIR Jul 2001
$595.00 - Available for Instant DownloadIssued: 12 Jul 2001Type: Medical Devices & Rad HealthOrtho Clinical Diagnostics - Rochester, NY, United States
C.R. Bard 483 Mar 2001
$119.00 - Available for Instant DownloadIssued: 30 Mar 2001Type: Medical Devices & Rad HealthC.R. Bard - Queensbury, NY, United States
Wyeth Pharmaceuticals, a subsidiary of Pfizer 483 Feb 2001
$119.00 - Available for Instant DownloadIssued: 01 Feb 2001Type: Human DrugsWyeth Pharmaceuticals, a subsidiary of Pfizer - Rouses Point, NY, United States
Wyeth Pharmaceuticals, a subsidiary of Pfizer 483 Response Feb 2001
$119.00 - Available for Instant DownloadIssued: 01 Feb 2001Type: Human DrugsWyeth Pharmaceuticals, a subsidiary of Pfizer - Rouses Point, NY, United States
Wyeth Pharmaceuticals, a subsidiary of Pfizer 483 Nov 2000
$119.00 - Available for Instant DownloadIssued: 09 Nov 2000Type: Human DrugsWyeth Pharmaceuticals, a subsidiary of Pfizer - Rouses Point, NY, United States
AMRI Rensselaer EIR May 2000
$595.00 - Available for Instant DownloadIssued: 30 May 2000Type: Human DrugsAMRI Rensselaer - Rensselaer, NY, United States
GlaxoSmithKline 483 May 2000
$119.00 - Available for Instant DownloadIssued: 05 May 2000Type: Human DrugsGlaxoSmithKline - East Durham, NY, United States
GlaxoSmithKline EIR May 2000
$595.00 - Available for Instant DownloadIssued: 05 May 2000Type: Human DrugsGlaxoSmithKline - East Durham, NY, United States